Zeffren J - Search Results

1

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. Among authors: zeffren j. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.

2

A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.

Whitehead RP, Figlin R, Citron ML, Pfile J, Moldawer N, Patel D, Jones G, Levitt D, Zeffren J. Whitehead RP, et al. Among authors: zeffren j. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):117-21. doi: 10.1097/00002371-199302000-00006. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8318496 Clinical Trial.

3

Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.

Hirsh M, Lipton A, Harvey H, Givant E, Hopper K, Jones G, Zeffren J, Levitt D. Hirsh M, et al. Among authors: zeffren j. J Clin Oncol. 1990 Oct;8(10):1657-63. doi: 10.1200/JCO.1990.8.10.1657. J Clin Oncol. 1990. PMID: 2213102

4

Interleukin-2 and interferon-alpha-2a outpatient therapy for metastatic renal cell carcinoma.

Lipton A, Harvey H, Givant E, Hopper K, Lawler J, Matthews Y, Hirsh M, Zeffren J. Lipton A, et al. Among authors: zeffren j. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):122-9. doi: 10.1097/00002371-199302000-00007. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8318497

5

A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.

Huberman M, Bering H, Fallon B, Tessitore J, Sonnenborn H, Paul S, Zeffren J, Levitt D, Groopman J. Huberman M, et al. Among authors: zeffren j. Cancer. 1991 Oct 15;68(8):1708-13. doi: 10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v. Cancer. 1991. PMID: 1913512 Clinical Trial.

6

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.

Olsen EA, Rosen ST, Vollmer RT, Variakojis D, Roenigk HH Jr, Diab N, Zeffren J. Olsen EA, et al. Among authors: zeffren j. J Am Acad Dermatol. 1989 Mar;20(3):395-407. doi: 10.1016/s0190-9622(89)70049-9. J Am Acad Dermatol. 1989. PMID: 2783939 Clinical Trial.

7

A phase II trial of interleukin-2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinoma.

Mittelman A, Puccio C, Ahmed T, Zeffren J, Choudhury A, Arlin Z. Mittelman A, et al. Among authors: zeffren j. Cancer. 1991 Oct 15;68(8):1699-702. doi: 10.1002/1097-0142(19911015)68:8<1699::aid-cncr2820680808>3.0.co;2-#. Cancer. 1991. PMID: 1717125 Clinical Trial.

8

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.

Bunn PA Jr, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Bunn PA Jr, et al. Among authors: zeffren j. Ann Intern Med. 1984 Oct;101(4):484-7. doi: 10.7326/0003-4819-101-4-484. Ann Intern Med. 1984. PMID: 6332565

9

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.

Foon KA, Sherwin SA, Abrams PG, Longo DL, Fer MF, Stevenson HC, Ochs JJ, Bottino GC, Schoenberger CS, Zeffren J, et al. Foon KA, et al. Among authors: zeffren j. N Engl J Med. 1984 Nov 1;311(18):1148-52. doi: 10.1056/NEJM198411013111803. N Engl J Med. 1984. PMID: 6482933

10

Biologic therapy of cancer.

Dunton AW, Hanagan J, Levitt D, Spiegel RJ, Zeffren J. Dunton AW, et al. Among authors: zeffren j. N J Med. 1990 Nov;87(11 Spec No):895-8. N J Med. 1990. PMID: 2274296 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters